These assays additionally enable the discovery that BET inhibitor I‐BET726 targets both Bdf1 BDs, inhibits the growth of a broad spectrum of Candida species, including antifungal‐resistant clinical isolates, and displays efficacy in an invertebrate animal model of infection. Here, DNER is linked to infection.